BPC-157 (Body Protection Compound-157) Disclaimer: BPC-157 is sold only for research and is not a medicinal product
History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
In a 2025 review, Sikiric and his team report that the study found the peptide was safe and well-tolerated, but they have not published the data
10.1186/s12989-018-0245-5 194 VoinovM
Understanding exactly what IGF-1 LR3 does, how it differs from other IGF variants, and how to use it safely requires diving deep into the science
Syringe Type Matters U-100 insulin syringes (100 units per mL) are the standard for peptide reconstitution work, but not universal U-40 and 1mL tuberculin syringes use different unit scales
